臨床神経学

<シンポジウム23―1>神経疾患に対する細胞治療の開発〜現状と展望

中枢神経疾患に対する細胞治療の展望と課題(オーバービュー)

高橋 良輔, 近藤 孝之

京都大学医学部神経内科〔〒606―8507 京都市左京区聖護院川原町54〕

iPS cells have opened up a revolutionarily new era for disease researches and regenerative medicine. Disesespecific iPS cells have tremendous promise for the understanding of pathogenesis of numerous intractable brain diseases. Cell transplantation therapies using somatic stem cells, ES cells and iPS cells are also promising, although ethical issues should be cleared and a lot of problems should be solved by technical innovations before they go into clinics.
Full Text of this Article in Japanese PDF (526K)

(臨床神経, 51:1075−1077, 2011)
key words:iPS cells, ES cells, somatic stem cells, Parkinson's disease, cerebral infarction

(受付日:2011年5月20日)